Your browser doesn't support javascript.
loading
Unplanned Excision of Synovial Sarcoma: Factors Associated with Recurrence and Survival.
Broida, Samuel E; Arguello, Alexandra M; Sullivan, Mikaela H; Robinson, Steven I; Okuno, Scott H; Siontis, Brittany L; Ho, Thanh P; Rose, Peter S; Xu-Welliver, Meng; Houdek, Matthew T.
Afiliação
  • Broida SE; Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
  • Arguello AM; Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
  • Sullivan MH; Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
  • Robinson SI; Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.
  • Okuno SH; Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.
  • Siontis BL; Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.
  • Ho TP; Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.
  • Rose PS; Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
  • Xu-Welliver M; Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA.
  • Houdek MT; Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
Cancers (Basel) ; 16(18)2024 Sep 14.
Article em En | MEDLINE | ID: mdl-39335129
ABSTRACT

Background:

Synovial sarcoma is rare and may present as a small, slow-growing mass. These tumors are often mistaken as benign and are therefore prone to unplanned and/or non-oncologic excision. We sought to identify the rate of unplanned excision of synovial sarcoma and risk factors for recurrence and survival among this cohort.

Methods:

The medical records of 246 patients evaluated at a single institution for synovial sarcoma between 1997 and 2022 were retrospectively reviewed. Of these, 87 (35%) underwent unplanned, non-oncologic excision. The mean age of the cohort was 49 years. Primary tumors were located in the extremity (n = 63), abdomen (n = 6), thorax (n = 7), head/neck (n = 8), and paraspinal region (n = 3). The median maximum pre-treatment dimension of the primary tumor was 4.8 cm (IQR 7-2.4). Seventy-seven (86%) patients underwent re-excision of the tumor bed, 39 (45%) received chemotherapy, and 63 (72%) received radiation therapy.

Results:

Among patients who underwent unplanned excision, local recurrence-free survival (LRFS) was 98% at 1 year and 82% at 5 years. Metastasis-free survival (MFS) was 91% at 1 year and 72% at 5 years. Disease-specific survival (DSS) was 98% at 1 year and 72% at 5 years. When adjusting for tumor size, tumors which underwent unplanned excision did not have worse recurrence or survival compared to those which had planned excision (p > 0.10). Size > 5 cm, monophasic subtype, and axial location were associated with increased risk of disease recurrence. Forty-six patients had residual tumor following re-excision, which was associated with worse MFS (HR 8.17, 95% CI [1.89, 35.2], p < 0.01) and DSS (HR 7.66, 95% CI [1.76, 33.4], p < 0.01). Patients who received radiotherapy had improved MFS (HR 6.4, 95% CI [1.42, 29.0], p = 0.02) and DSS (HR 5.86, 95% CI [1.27, 26.9], p = 0.02).

Conclusions:

One-third of patients presenting with synovial sarcoma were diagnosed after unplanned, non-oncologic excision. Patients with large, axial tumors had worse survival. Approximately half of patients who underwent unplanned excision had no residual tumor after pre-operative radiation. The use of radiation was associated with decreased rates of recurrence and improved disease-specific survival. Our results suggest that margin-negative re-resection and radiotherapy should be considered when feasible following unplanned excision of synovial sarcoma.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article